Symptoms and complications for many patients can be controlled or reduced by following a regular treatment plan. The early signs and symptoms of ankylosing spondylitis might include pain and stiffness in the lower back and hips, especially in the morning and after periods of inactivity. Neck pain and fatigue also are common. Over time, symptoms might worsen, improve or stop at irregular intervals.
Ankylosing Spondylitis Market Report Highlights
AspectsDetailsBy Drug Class
- NSAIDs
- TNF inhibitors
- Others
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Region
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia Pacific)
- LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
By Key Market Players
- AbbVie, Inc,
- Amgen, Inc,
- Eli Lilly and Company
- Gilead Sciences
- Janssen Pharmaceuticals
- Merck & Co. Inc
- Novartis AG,
- Pfizer, Inc
- Reliance Life Sciences Pvt. Ltd
- UCB, Inc.,